RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 623.00
+16.00 (2.64%)
Oct 6, 2026, 3:30 PM JST
RaQualia Pharma Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15,801 | 24,702 | 8,386 | 14,874 | 25,843 | 24,601 | |
Market Cap Growth | 9.50% | 194.57% | -43.62% | -42.44% | 5.05% | 17.42% |
Enterprise Value | 13,789 | 24,208 | 8,784 | 11,061 | 22,328 | 21,890 |
Last Close Price | 607.00 | 1010.00 | 384.00 | 688.00 | 1232.00 | 1174.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 95.96 | 90.48 | - | - | 35.74 | 32.58 |
Forward PE | - | 16.89 | 15.07 | 19.50 | 74.48 | 78.27 |
PS Ratio | 4.05 | 6.21 | 2.70 | 7.83 | 8.86 | 8.86 |
PB Ratio | 2.02 | 3.58 | 1.51 | 2.43 | 4.70 | 5.14 |
P/TBV Ratio | 3.72 | 7.81 | 5.03 | 2.44 | 4.72 | 5.18 |
P/FCF Ratio | 34.28 | - | 99.83 | - | 17.84 | 89.79 |
P/OCF Ratio | 31.54 | - | 46.59 | - | 17.46 | 67.22 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.54 | 6.08 | 2.83 | 5.82 | 7.65 | 7.89 |
EV/EBITDA Ratio | 17.00 | 24.96 | 46.72 | - | 22.02 | 25.78 |
EV/EBIT Ratio | 41.16 | 50.12 | - | - | 25.75 | 30.92 |
EV/FCF Ratio | 29.91 | - | 104.57 | - | 15.41 | 79.89 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.34 | 0.42 | 0.62 | 0.06 | 0.04 | 0.01 |
Debt / EBITDA Ratio | 3.31 | 2.99 | 18.35 | - | 0.22 | 0.04 |
Debt / FCF Ratio | 5.82 | - | 41.07 | - | 0.15 | 0.14 |
Net Debt / Equity Ratio | -0.26 | -0.05 | 0.02 | -0.56 | -0.67 | -0.55 |
Net Debt / EBITDA Ratio | -2.48 | -0.35 | 0.58 | 20.97 | -3.65 | -3.09 |
Net Debt / FCF Ratio | -4.36 | 0.82 | 1.30 | 3.68 | -2.56 | -9.56 |
Asset Turnover | 0.37 | 0.40 | 0.38 | 0.29 | 0.51 | 0.59 |
Inventory Turnover | 3.96 | 4.37 | 3.98 | 3.16 | 25.67 | 40.13 |
Quick Ratio | 5.18 | 4.06 | 3.40 | 11.22 | 9.18 | 9.66 |
Current Ratio | 5.78 | 4.46 | 3.82 | 12.74 | 9.78 | 10.01 |
Return on Equity (ROE) | 2.28% | 4.38% | -8.47% | -5.56% | 14.06% | 17.17% |
Return on Assets (ROA) | 2.00% | 2.99% | -1.61% | -3.21% | 9.43% | 9.33% |
Return on Invested Capital (ROIC) | 2.20% | 4.93% | -5.07% | -14.93% | 37.26% | 29.61% |
Return on Capital Employed (ROCE) | 3.40% | 5.20% | -2.50% | -5.20% | 15.00% | 14.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.02% | 1.10% | -5.90% | -2.17% | 2.80% | 3.07% |
FCF Yield | 2.92% | -1.70% | 1.00% | -6.21% | 5.61% | 1.11% |
Buyback Yield / Dilution | -14.40% | -11.14% | -0.16% | -2.97% | -0.05% | -0.10% |